PRN: Global Drug Delivery in Cancer Technologies, Markets and Companies 2016-2026 with Profiles of 234 Companies Involved in Developing Innovative Cancer Therapies

07/lug/2017 19:00:12 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Drug Delivery in Cancer Technologies, Markets and Companies 2016-2026 with Profiles of 234 Companies Involved in Developing Innovative Cancer Therapies

 
[07-July-2017]
 

DUBLIN, July 7, 2017 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Cancer - Technologies, Markets and Companies" to their offering.

Logo

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches to cancer treatment not only supplement the conventional chemotherapy and radiotherapy but also prevent damage to normal tissues and prevent drug resistance.

Innovative cancer therapies are based on current concepts of molecular biology of cancer. These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine kinase receptors, antisense approaches, gene therapy and combination of various methods. Important methods of immunotherapy in cancer involve use of cytokines, monoclonal antibodies, cancer vaccines and immunogene therapy.

Drug delivery strategies vary according to the type and location of cancer. Role of drug delivery in the management of cancers of the brain, the bladder, the breast, the ovaries and the prostate are used as examples to illustrate different approaches both experimental and clinical. Biodegradable implants of carmustine are already used in the treatment of malignant brain tumors.


The market value of drug delivery technologies and the anticancer drugs are difficult to separate. Cancer market estimates from 2016-2026 are given according to organs involved and the types of cancer as well as according to technologies. Distribution of the into major regions is also described.



Profiles of 234 companies involved in developing innovative cancer therapies and methods of delivery are presented along with their 278 collaborations. The bibliography contains over 650 publications that are cited in the report.The report is supplemented with 65 tables and 13 figures.

Key Topics Covered:





Part I: Technologies & Markets



Executive Summary



1. Introduction to cancer therapy



2. Innovative treatments for cancer



3. Drug delivery systems for cancer



4. Delivery of Biological Therapies for Cancer



5. Delivery strategies according to cancer type and location



6. Cancer drug delivery markets



7. References



Part II: Companies



8. Companies involved in cancer drug delivery



For more information about this report visit

https://www.researchandmarkets.com/research/2s4gmd/drug_delivery_in

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl